Clinicopathological Characteristics and Prognosis of Gastrointestinal Cancer with Neuroendocrine Differentiation.

Meili Chen,Jieyu Chen,Lixia Yu,Xiaoping Qian,Baorui Liu,Jia Wei,Mi Yang
DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.e16161
IF: 45.3
2018-01-01
Journal of Clinical Oncology
Abstract:e16161 Background: The phenomenon of neuroendocrine differentiation (NED) has been observed in gastrointestinal cancer for some time. However, the clinicopathological characteristics and prognosis of gastrointestinal cancer with neuroendocrine differentiation (GI-NED) remains controversial. Methods: This study collected 112 GI-NED patients with clear clinicopathological characteristics from Nanjing Drum Tower Hospital from January 2010 to November 2017. Survival rate was calculated by Kaplan-Meier curve and multivariate prognostic risk factors were analyzed by COX regression model. Results: 112 patients with GI-NED have the following characteristics: more male patients (79.5%), more located in stomach (87.5%), more in low degree of differentiation (89.3%), more in T3/T4 (73.2%), and main histological type was common adenocarcinoma (94.6%). The positive expression rates of CgA and Syn were 70.5% and 74.1%, both expression rate was 44.6%. Survival analysis showed no significant difference in survival curves between patients with high expression and low expression of neuroendocrine markers (P = 0.806, P = 0.766). Multivariate analysis showed that the patient age, tumor location and TNM stage were the risk factors affecting the prognosis (P < 0.05). Conclusions: Immunohistochemistry is the main method to diagnose GI-NED. Our study shows that the age, tumor location and TNM stage are related to the prognosis of patients. The expression of neuroendocrine markers Syn and CgA have no correlation with the prognosis of GI-NED.
What problem does this paper attempt to address?